Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.99
(
-0.21%
)
Bitcoin
78,310.23
(
0.04%
)
News Focus
News Focus
Post# of 822652
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

dstock07734

Send PM Follow Ignore
Followers 76
Posts 6475
Boards Moderated 0
Alias Born 05/25/2021

dstock07734

Re: HyGro post# 523055

Wednesday, 10/19/2022 12:50:15 PM

Wednesday, October 19, 2022 12:50:15 PM

Post# of 822652
The reason NWBO adopted new primary ending point is because of pseudoprogression. That's why the trial took so long becuase they had to use OS as primary ending point. Did I get that right?

Is Data manipulation in clinical trials a crime? It is very serious accusation. If you are so sure about it, file Citizen Petition to FDA for the good of the public.

https://www.fda.gov/regulatory-information/dockets-management/instructions-submitting-citizen-petitions-cps-electronically
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News